drugset / Trial / NCT01977196

The Safety and Immunogenicity of DTP/Hepatitis B 10ug Hib Vaccine (Bio Farma)

NCT01977196 ↗

Phase 1 Completed 30 enrolled PT Bio Farma
NaSingle-groupOpen-labelPrevention

Summary

The objective of this study was to know the safety of DTP/Hepatitis B and Hib/PRP-T vaccine and immediate reactions within the first 30 minutes after injection.

Timeline

Start
2011-04
Primary completion
2011-07
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Subject DPT/HepatitisB/Hib vaccine Vaccine — Other

Indications

No indication recorded.